Colorectal Cancer: Individualizing Treatment, Improving Outcomes

EP. 1: Deciding on Adjuvant Therapy in CRC

February 26th 2018

EP. 2: Duration of Adjuvant Therapy: CRC Subsets

February 26th 2018

EP. 3: Managing Patients After Adjuvant Therapy

February 26th 2018

EP. 4: Treating Liver or Peritoneal Metastases in CRC

February 26th 2018

EP. 5: Early-Onset CRC: What Do We Know?

February 26th 2018

EP. 6: Role of Molecular Testing in CRC Management

February 26th 2018

EP. 7: Importance of HER2 Expression in CRC

February 26th 2018

EP. 8: Left- Versus Right-Sided Tumors in CRC

February 26th 2018

EP. 9: Frontline Antibody Selection in Metastatic CRC

February 26th 2018

EP. 10: Maintenance and Second-Line Decisions in CRC

February 26th 2018

EP. 11: Supportive Care in Metastatic CRC

February 26th 2018

EP. 12: Immunotherapy Options in Refractory CRC

February 26th 2018

EP. 13: Third-Line Treatment in Refractory CRC

February 26th 2018

EP. 14: Dosing and Side Effect Management in Metastatic CRC

February 26th 2018

EP. 15: Managing Toxicities With Immunotherapy in CRC

February 26th 2018

EP. 16: Emerging Immunotherapy Combinations in MSS CRC

February 26th 2018

EP. 17: Progress in CRC Precision Medicine

February 26th 2018

EP. 18: Improving Outcomes in CRC

February 26th 2018